• 
  Pierre Mordant, Solenn Brosseau, Bernard Milleron, Nicola Santelmo, Séverine Fraboulet-Moreau, et al.. Outcome of Patients With Resected Early-Stage Non-small Cell Lung Cancer and EGFR Mutations: Results From the IFCT Biomarkers France Study. Clinical Lung Cancer, 2023, 24 (1), pp.1-10. ⟨10.1016/j.cllc.2022.08.013⟩. ⟨hal-03800571⟩
• 
  Matthieu Duchmann, Jean-Baptiste Micol, Nicolas Duployez, Emmanuel Raffoux, Xavier Thomas, et al.. Prognostic significance of concurrent gene mutations i n intensively treated patients with IDH-mutated AML: an ALFA study. Blood, 2021, 137 (20), pp.2827-2837. ⟨10.1182/blood.2020010165⟩. ⟨hal-03604929⟩
• 
  Marius Ilié, Julien Mazières, Emmanuel Chamorey, Simon Heeke, Jonathan Benzaquen, et al.. Prospective Multicenter Validation of the Detection of ALK Rearrangements of Circulating Tumor Cells for Noninvasive Longitudinal Management of Patients With Advanced NSCLC. Journal of Thoracic Oncology, 2021, 16 (5), pp.807-816. ⟨10.1016/j.jtho.2021.01.1617⟩. ⟨hal-03663313⟩
• 
  Florence Duffaud, Antoine Italiano, Emannuelle Bompas, Maria Rios, Nicolas Penel, et al.. Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study. European Journal of Cancer, 2021, 150, pp.108-118. ⟨10.1016/j.ejca.2021.03.039⟩. ⟨hal-03623638⟩
• 
  Yann‐alexandre Vano, Letuan Phan, Gwenaelle Gravis, Iphigénie Korakis, Friederike Schlürmann, et al.. Cabozantinib-nivolumab sequence in metastatic renal cell carcinoma: The CABIR study. International Journal of Cancer, 2022, 151 (8), pp.1335-1344. ⟨10.1002/ijc.34126⟩. ⟨hal-04085018⟩
• 
  Mathias Neron, Arnaud Guille, Lucie Allègre, Pierre-Emmanuel Colombo, Cristina Marinella Leaha, et al.. Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy. Journal of Personalized Medicine, 2022, 12 (5), pp.655. ⟨10.3390/jpm12050655⟩. ⟨hal-03765663⟩
• 
  Éric Leblanc, Fabrice Narducci, Gwénaël Ferron, Audrey Mailliez, Jean Yves Charvolin, et al.. Prophylactic Radical Fimbriectomy with Delayed Oophorectomy in Women with a High Risk of Developing an Ovarian Carcinoma: Results of a Prospective National Pilot Study. Cancers, 2023, 15 (4), ⟨10.3390/cancers15041141⟩. ⟨hal-04068556⟩
• 
  Claudia Pasqualini, Jonathan Rubino, Caroline Brard, Lydie Cassard, Nicolas André, et al.. Phase II and biomarker study of programmed cell death protein 1 inhibitor nivolumab and metronomic cyclophosphamide in paediatric relapsed/refractory solid tumours: Arm G of AcSé-ESMART, a trial of the European Innovative Therapies for Children With Cancer Consortium. European Journal of Cancer, 2021, 150, pp.53-62. ⟨10.1016/j.ejca.2021.03.032⟩. ⟨hal-03625350⟩
• 
  Nora Moumjid, Marie-Anne Durand, Julien Carretier, Elodie Charuel, Jocelyne Daumer, et al.. Implementation of shared decision-making and patient-centered care in France: Towards a wider uptake in 2022. Z Evid Fortbild Qual Gesundhwes / Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 2022, 171, pp.42 - 48. ⟨10.1016/j.zefq.2022.03.001⟩. ⟨inserm-04053232⟩
• 
  Luciana L. Almada, Kim Barroso, Sandhya Sen, Murat Törüner, Ashley N Sigafoos, et al.. GLI1, a novel target of the ER stress regulator p97/VCP, promotes ATF6f-mediated activation of XBP1. Biochimica et Biophysica Acta - Gene Regulatory Mechanisms , 2023, 1866, pp.194924. ⟨10.1016/j.bbagrm.2023.194924⟩. ⟨hal-04016307⟩
• 
  Olivier Bylicki, Pascale Tomasini, Gervais Radj, Florian Guisier, Isabelle Monnet, et al.. Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018. European Journal of Cancer, 2023, 183, pp.38-48. ⟨10.1016/j.ejca.2023.01.014⟩. ⟨hal-04016683⟩
• 
  Laurys Boudin, A de Nonneville, Pascal Finetti, Léna Mescam, A Le Cesne, et al.. CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response. Journal of Translational Medicine, 2022, 20 (1), pp.464. ⟨10.1186/s12967-022-03679-y⟩. ⟨hal-03958345⟩
• 
  Priyanka Devi-Marulkar, Solène Fastenackels, Pierre Karapentiantz, Jérémy Goc, Claire Germain, et al.. Regulatory T cells infiltrate the tumor-induced tertiary lymphoïd structures and are associated with poor clinical outcome in NSCLC. Communications Biology, 2022, 5 (1), pp.1416. ⟨10.1038/s42003-022-04356-y⟩. ⟨inserm-03958203⟩
• 
  Violaine Randrian, Simon Pernot, Karine Le Malicot, Vittorio Catena, Isabelle Baumgaertner, et al.. FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancer. Digestive and Liver Disease, 2022, 54 (7), pp.857-863. ⟨10.1016/j.dld.2022.04.024⟩. ⟨hal-03906999⟩
• 
  Mohamad Mohty, Didier Blaise, Régis Peffault de Latour, Myriam Labopin, Jean Henri Bourhis, et al.. Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study. Bone Marrow Transplantation, 2022, ⟨10.1038/s41409-022-01900-6⟩. ⟨hal-03915550⟩
• 
  Célestin BIGARRÉ, François Bertucci, Pascal Finetti, Gaëtan Macgrogan, Xavier Muracciole, et al.. Mechanistic modeling of metastatic relapse in early breast cancer to investigate the biological impact of prognostic biomarkers. 2022. ⟨hal-03936594⟩
• 
  Rania Ghossoub, Louise Lindbæk, Anahi Mollà-Herman, Alain Schmitt, Søren Tvorup Christensen, et al.. Morphological and Functional Characterization of the Ciliary Pocket by Electron and Fluorescence Microscopy. Methods Mol Biol, 1454, pp.35-51, 2016, ⟨10.1007/978-1-4939-3789-9_3⟩. ⟨inserm-02263792⟩
• 
  Fabrice Barlesi, Laurent Greillier, Florence Monville, C Audigier-Valette, S. Martinez, et al.. 3MO - Comprehensive biomarkers (BMs) analysis to predict efficacy of PD1/L1 immune checkpoint inhibitors (ICIs) in combination with chemotherapy: a subgroup analysis of the Precision Immuno-Oncology for advanced Non-Small CEll Lung CancER (PIONeeR) trial. ESMO Immuno-Oncology, Dec 2022, Geneva, Switzerland. ⟨hal-03928784⟩
• 
  Sébastien Benzekry, Mathieu Grangeon, Mélanie Karlsen, Pauline Fleury, Maria Alexa, et al.. Machine learning for prediction of immunotherapy efficacy in nonsmall cell lung cancer from simple clinical and biological data. WCoP 2022 - World Conference on Pharmacometrics, Mar 2022, Cape Town, South Africa. ⟨hal-03935743⟩
• 
  Aude Merdrignac, Jonathan Garnier, Safi Dokmak, Nicolas Regenet, Mickael Lesurtel, et al.. Effect of the Use of Reinforced Stapling on the Occurrence of Pancreatic Fistula after Distal Pancreatectomy: Results of the REPLAY Multicenter Randomized clinical trial REPLAY: REinforcement of the Pancreas in distaL pAncreatectomY. Annals of Surgery, 2022, 276 (5), pp.769-775. ⟨10.1097/SLA.0000000000005618⟩. ⟨hal-03776322⟩

233

367